These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19939367)
41. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study. Butler AE; Ramachandran V; Cunningham TK; David R; Gooderham NJ; Benurwar M; Dargham SR; Hayat S; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL Front Endocrinol (Lausanne); 2020; 11():571357. PubMed ID: 33101204 [TBL] [Abstract][Full Text] [Related]
42. Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS. Shukla P; Melkani GC Rev Endocr Metab Disord; 2023 Apr; 24(2):317-326. PubMed ID: 36705802 [TBL] [Abstract][Full Text] [Related]
43. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome. Deswal R; Nanda S; Dang AS Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034 [TBL] [Abstract][Full Text] [Related]
44. Changes in sexual function among women with polycystic ovary syndrome: a pilot study. Ferraresi SR; Lara LA; Reis RM; Rosa e Silva AC J Sex Med; 2013 Feb; 10(2):467-73. PubMed ID: 23210985 [TBL] [Abstract][Full Text] [Related]
45. Assessing global and gene specific DNA methylation in anorexia nervosa: a pilot study. Saffrey R; Novakovic B; Wade TD Int J Eat Disord; 2014 Mar; 47(2):206-10. PubMed ID: 24115305 [TBL] [Abstract][Full Text] [Related]
46. [Epigenetic background of the most common non-oncologic gynecological diseases]. Joó JG; Csatlós E; Brubel R; Bokor A; Karabélyos C; Rigó J Orv Hetil; 2014 Mar; 155(13):492-9. PubMed ID: 24659742 [TBL] [Abstract][Full Text] [Related]
47. Electroacupuncture Mimics Exercise-Induced Changes in Skeletal Muscle Gene Expression in Women With Polycystic Ovary Syndrome. Benrick A; Pillon NJ; Nilsson E; Lindgren E; Krook A; Ling C; Stener-Victorin E J Clin Endocrinol Metab; 2020 Jun; 105(6):2027-41. PubMed ID: 32232327 [TBL] [Abstract][Full Text] [Related]
48. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. Shukla P; Mukherjee S Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727 [TBL] [Abstract][Full Text] [Related]
49. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome. Ting W; Yanyan Q; Jian H; Keqin H; Duan M Cell Biochem Biophys; 2013; 67(3):1041-7. PubMed ID: 23605101 [TBL] [Abstract][Full Text] [Related]
50. Editorial: Epigenetics of polycystic ovary syndrome. Parker J; Kunicki M Front Endocrinol (Lausanne); 2023; 14():1284351. PubMed ID: 37766688 [No Abstract] [Full Text] [Related]
51. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. Sun J; Fan H; Che Y; Cao Y; Wu X; Sun HX; Liang F; Yi L; Wang Y BMC Med Genet; 2009 Jul; 10():64. PubMed ID: 19602270 [TBL] [Abstract][Full Text] [Related]
52. [Relation between insulin resistance and insulin receptor gene methylation in the endometrium of patients with polycystic ovary syndrome]. Lin Y; Xing FQ; Ou ZY; Liang JL; Wen AM; Chen Y Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):867-70. PubMed ID: 21602145 [TBL] [Abstract][Full Text] [Related]
53. A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Homburg R; Gudi A; Shah A; M Layton A Reprod Biol Endocrinol; 2017 Aug; 15(1):61. PubMed ID: 28789693 [TBL] [Abstract][Full Text] [Related]
54. Single-Nucleotide Polymorphism on Exon 17 of Insulin Receptor Gene Influences Insulin Resistance in PCOS: A Pilot Study on North Indian Women. Gangopadhyay S; Agrawal N; Batra A; Kabi BC; Gupta A Biochem Genet; 2016 Apr; 54(2):158-68. PubMed ID: 26721804 [TBL] [Abstract][Full Text] [Related]
55. The role of MiRNA in polycystic ovary syndrome (PCOS). Chen B; Xu P; Wang J; Zhang C Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362 [TBL] [Abstract][Full Text] [Related]
56. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. Hickey TE; Legro RS; Norman RJ J Clin Endocrinol Metab; 2006 Jul; 91(7):2789-91. PubMed ID: 16636126 [TBL] [Abstract][Full Text] [Related]
57. Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant. Wang Y; Qu J; Wu X; Hou L; Erkkola R; Wang Y Fertil Steril; 2010 Mar; 93(4):1362-5. PubMed ID: 19782351 [TBL] [Abstract][Full Text] [Related]
58. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. Dunaif A J Clin Endocrinol Metab; 2016 Mar; 101(3):759-68. PubMed ID: 26908109 [TBL] [Abstract][Full Text] [Related]
59. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422 [TBL] [Abstract][Full Text] [Related]
60. Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome. Knebel B; Lehr S; Janssen OE; Hahn S; Jacob S; Nitzgen U; Müller-Wieland D; Kotzka J Mol Biol Rep; 2017 Feb; 44(1):51-61. PubMed ID: 27878529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]